Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 17 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. | 1,195,035 | reported | 18 May 2026 | tx 66+7,959,603−1,309,854 |
| PHARMACYCLICS INC | 275,000 | reported | 18 Mar 2008 | tx 7+807,000 |
| Bolt Biotherapeutics, Inc. | 25,000 | reported | 12 Jun 2023 | tx 4+100,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | PURCHASE | Corvus Pharmaceuticals, Inc. | 5,000 | 12.05 USD | |
| 18 May 2026 | PURCHASE | Corvus Pharmaceuticals, Inc. | 1,932 | 12.01 USD | first after silence |
| 04 Dec 2025 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 1,000,000 | 0.00 USD | deriv |
| 07 May 2025 | EXERCISE | Corvus Pharmaceuticals, Inc. | 559,073 | 3.50 USD | |
| 07 May 2025 | EXERCISE | Corvus Pharmaceuticals, Inc. | 559,073 | — | deriv |
| 20 Dec 2024 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 750,000 | 0.00 USD | deriv |
| 10 May 2024 | GIFT | Corvus Pharmaceuticals, Inc. | 302,016 | 0.00 USD | |
| 06 May 2024 | PURCHASE | Corvus Pharmaceuticals, Inc. | 577,634 | 1.73 USD | |
| 06 May 2024 | PURCHASE | Corvus Pharmaceuticals, Inc. | 559,073 | — | derivfirst after silence |
| 06 Dec 2023 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 500,000 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 31 Mar 2023 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 800,000 | 0.00 USD | deriv |
| 14 Dec 2022 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 13 Dec 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 50,000 | 0.74 USD | |
| 14 Dec 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 10,000 | 0.78 USD | |
| 28 Sept 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 25,000 | 0.76 USD | |
| 20 Sept 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 2,700 | 0.82 USD | |
| 20 Sept 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 5,000 | 0.82 USD | |
| 20 Sept 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 12,300 | 0.81 USD | |
| 11 Aug 2022 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 320,000 | 0.00 USD | deriv |
| 24 Jun 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 5,000 | 1.03 USD | |
| 27 Jun 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 5,000 | 1.00 USD | |
| 10 Jun 2022 | GRANT_AWARD | Bolt Biotherapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 02 Jun 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 4,830 | 0.98 USD | |
| 06 Jun 2022 | PURCHASE | Corvus Pharmaceuticals, Inc. | 890 | 1.01 USD |
5 purchases reported after at least 12 months of silence — most recent on 18 May 2026.